{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:21:19Z","timestamp":1795173679814,"version":"4.10.3"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00287","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T05:20:07Z","timestamp":1563254407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Hypertension in Childhood Nephrotic Syndrome"],"prefix":"10.3389","volume":"7","author":[{"given":"Ibrahim F.","family":"Shatat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren J.","family":"Becton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Woroniecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00467-006-0410-1","article-title":"Chronic kidney disease in children: the global perspective","volume":"22","author":"Warady","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fped.2016.00039","article-title":"Ethnic differences in childhood nephrotic syndrome","volume":"4","author":"Chanchlani","year":"2016","journal-title":"Front Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/adc.57.7.544","article-title":"Long-term outcome of primary nephrotic syndrome","volume":"57","author":"Koskimies","year":"1982","journal-title":"Arch Dis Child."},{"key":"B4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(66)92253-7","article-title":"Long-term assessment of steroid therapy in childhood nephrosis","volume":"2","author":"Arneil","year":"1966","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the international study of kidney disease in children","volume":"98","year":"1981","journal-title":"J Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ki.1981.209","article-title":"A report of the international study of kidney disease in children","volume":"20","year":"1981","journal-title":"Kidney Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2215\/CJN.06260614","article-title":"Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort","volume":"10","author":"Trautmann","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s00467-006-0413-y","article-title":"Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis","volume":"22","author":"Shatat","year":"2007","journal-title":"Pediatr Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s10157-018-1565-3","article-title":"Hypertension and its severity in children with steroid sensitive nephrotic syndrome during remission","volume":"22","author":"Keshri","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000168198","article-title":"Blood pressure in minimal change and other types of nephrotic syndrome","volume":"10","author":"K\u00fcster","year":"1990","journal-title":"Am J Nephrol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000238823","article-title":"Blood pressure in children with minimal change nephrotic syndrome during oedema and after steroid therapy: the influence of familial essential hypertension","volume":"32","author":"Kontchou","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1097\/01.ASN.0000089565.04535.4B","article-title":"Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"14","author":"Mitsnefes","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2215\/CJN.08330812","article-title":"Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS","volume":"8","author":"Hogg","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.108.110635","article-title":"Blood pressure in children with chronic kidney disease: a report from the chronic kidney disease in children study","volume":"52","author":"Flynn","year":"2008","journal-title":"Hypertension"},{"key":"B16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/HYPERTENSIONAHA.117.09475","article-title":"Blood pressure and visit-to-visit blood pressure variability among individuals with primary proteinuric glomerulopathies","volume":"70","author":"Sethna","year":"2017","journal-title":"Hypertension"},{"key":"B17","first-page":"271","article-title":"Nephrotic syndrome and hypertension","volume":"4","author":"Gabban","year":"2010","journal-title":"Iraqi J Comm Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00467-015-3174-7","article-title":"Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children","volume":"31","author":"Inaba","year":"2016","journal-title":"Pediatr Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12098-016-2207-y","article-title":"Ambulatory blood pressure monitoring in frequently relapsing nephrotic syndrome","volume":"84","author":"Sarkar","year":"2017","journal-title":"Indian J Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/10641963.2016.1235179","article-title":"Circadian blood pressure abnormalities in patients with primary nephrotic syndrome","volume":"39","author":"Haruhara","year":"2017","journal-title":"Clin Exp Hypertens"},{"key":"B21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00467-014-2955-8","article-title":"Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial","volume":"30","author":"Ishikura","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5414\/CN108044","article-title":"Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood","volume":"81","author":"Skrzypczyk","year":"2014","journal-title":"Clin Nephrol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","article-title":"Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences","volume":"90","author":"Vaziri","year":"2016","journal-title":"Kidney Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00467-008-1029-1","article-title":"Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome","volume":"24","author":"Kniazewska","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5414\/CN107760","article-title":"Increased arterial stiffness in patients with nephrotic syndrome","volume":"79","author":"Gungor","year":"2013","journal-title":"Clin Nephrol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10157-014-0958-1","article-title":"Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case-control study","volume":"19","author":"Rahul","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3265\/Nefrologia.pre2013.May.12036","article-title":"Carotid artery function in children with idiopathic nephrotic syndrome","volume":"33","author":"Hooman","year":"2013","journal-title":"Nefrologia."},{"key":"B28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00467-013-2608-3","article-title":"Subclinical cardiovascular disease and its association with risk factors in children with steroid-resistant nephrotic syndrome","volume":"29","author":"Candan","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ajhg.2018.08.004","article-title":"Genetic association of albuminuria with cardiometabolic disease and blood pressure","volume":"103","author":"Haas","year":"2018","journal-title":"Am J Hum Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1053\/j.ackd.2014.11.006","article-title":"Sodium retention and volume expansion in nephrotic syndrome: implications for hypertension","volume":"22","author":"Ray","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00467-013-2439-2","article-title":"Remission of nephrotic syndrome diminishes urinary plasmin content and abolishes activation of ENaC","volume":"28","author":"Andersen","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1681\/ASN.2008040364","article-title":"Plasmin in nephrotic urine activates the epithelial sodium channel","volume":"20","author":"Svenningsen","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ki.1989.161","article-title":"Blunted excretory response to atrial natriuretic peptide in experimental nephrosis","volume":"36","author":"Perico","year":"1989","journal-title":"Kidney Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1172\/JCI115995","article-title":"Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome","volume":"90","author":"Valentin","year":"1992","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/ki.1988.256","article-title":"Atrial natriuretic peptide and the renal response to hypervolemia in nephrotic humans","volume":"34","author":"Peterson","year":"1988","journal-title":"Kidney Int"},{"key":"B36","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/ki.2010.197","article-title":"Decreased renal corin expression contributes to sodium retention in proteinuric kidney diseases","volume":"78","author":"Polzin","year":"2010","journal-title":"Kidney Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0925-4439(03)00061-9","article-title":"Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria","volume":"1638","author":"Ni","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"B38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.33549\/physiolres.933332","article-title":"Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension","volume":"66","author":"Ho\u0161kov\u00e1","year":"2017","journal-title":"Physiol Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5301\/jn.5000174","article-title":"Pathogenesis of calcineurin inhibitor-induced hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J Nephrol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00467-003-1370-3","article-title":"Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome","volume":"19","author":"Loeffler","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/ndt\/gfi059","article-title":"Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience","volume":"20","author":"El-Husseini","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1291\/hypres.19.1","article-title":"Mechanism of glucocorticoid-induced hypertension","volume":"19","author":"Saruta","year":"1996","journal-title":"Hypertens Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/07435809509030436","article-title":"Study on the mechanisms of glucocorticoid-induced hypertension: glucocorticoids increase transmembrane Ca2+ influx in vascular smooth muscle in vivo","volume":"21","author":"Kornel","year":"1995","journal-title":"Endocr Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3109\/08037059409101518","article-title":"Studies on the mechanisms of glucocorticoid hypertension in humans","volume":"3","author":"Whitworth","year":"1994","journal-title":"Blood Press."},{"key":"B45","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/00004872-199405000-00003","article-title":"Increased expression of vascular angiotensin II type 1A receptor gene in glucocorticoid-induced hypertension","volume":"12","author":"Sato","year":"1994","journal-title":"J Hypertens."},{"key":"B46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ecl.2011.01.010","article-title":"How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids","volume":"40","author":"Ong","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B47","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.mnh.0000133976.32559.b0","article-title":"Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension","volume":"13","author":"Frey","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B48","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000184944","article-title":"Steroid-induced hypertension in patients with nephrotic syndrome","volume":"48","author":"Klepikov","year":"1988","journal-title":"Nephron."},{"key":"B49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.1970.03180020021004","article-title":"Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study","volume":"214","author":"Kannel","year":"1970","journal-title":"JAMA"},{"key":"B50","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM197210192871601","article-title":"Role of blood pressure in the development of congestive heart failure. The Framingham study","volume":"287","author":"Kannel","year":"1972","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000065227","article-title":"Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation","volume":"22","author":"Tylicki","year":"2002","journal-title":"Am J Nephrol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"v28","DOI":"10.1093\/ndt\/gfg1040","article-title":"The role of arterial hypertension in the progression of non-diabetic glomerular diseases","volume":"18","author":"Ljuti\u0107","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"B53","first-page":"S63","article-title":"Long-term progression of chronic renal insufficiency in the AIPRI extension study. The angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group","volume":"63","author":"Locatelli","year":"1997","journal-title":"Kidney Int Suppl."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)","volume":"349","author":"Randomised","year":"1997","journal-title":"Lancet"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children","volume":"361","author":"W\u00fchl","year":"2009","journal-title":"N Engl J Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000168052","article-title":"Role of aldosterone in the sodium retention of patients with nephrotic syndrome","volume":"10","author":"Shapiro","year":"1990","journal-title":"Am J Nephrol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.2215\/CJN.01410210","article-title":"Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome","volume":"5","author":"Schrier","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","article-title":"Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease","volume":"70","author":"Bianchi","year":"2006","journal-title":"Kidney Int"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1681\/ASN.2018010091","article-title":"DUET: a phase 2 study evaluating the efficacy and safety of sparsentan in patients with FSGS","volume":"29","author":"Trachtman","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/cells4040622","article-title":"Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies","volume":"4","author":"Duffy","year":"2015","journal-title":"Cells"},{"key":"B61","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jash.2014.09.019","article-title":"Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension","volume":"8","author":"Oxlund","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1046\/j.1523-1755.1998.00912.x","article-title":"Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?","volume":"53","author":"Kloke","year":"1998","journal-title":"Kidney Int."},{"key":"B63","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2796.1991.tb00325.x","article-title":"Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy","volume":"229","author":"Holdaas","year":"1991","journal-title":"J Intern Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e1000058","DOI":"10.1371\/journal.pmed.1000058","article-title":"The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors","volume":"6","author":"Danaei","year":"2009","journal-title":"PLoS Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1161\/HYP.0000000000000067","article-title":"Systematic review for the 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"71","author":"Reboussin","year":"2018","journal-title":"Hypertension"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-3035","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fped.2017.00138","article-title":"The microbiome and blood pressure:can microbes regulate our blood pressure?","volume":"5","author":"Al Khodor","year":"2017","journal-title":"Front Pediatr"},{"key":"B68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12882-018-0878-5","article-title":"Cardiovascular outcomes of Nephrotic syndrome in childhood (CVONS) study: a protocol for prospective cohort study","volume":"19","author":"Patnaik","year":"2018","journal-title":"BMC Nephrol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00287\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T21:21:23Z","timestamp":1610486483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00287\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":68,"alternative-id":["10.3389\/fped.2019.00287"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00287","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"article-number":"287"}}